Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas
✍ Scribed by Angels Sierra; Xavier Castellsagué; Toni Coll; Sandra Mañas; Agustin Escobedo; Abelardo Moreno; Angels Fabra
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 165 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Expression of the death-related proteins (DRPs) Bcl-2, Bax, Bcl-x and Bak that regulate cell survival and death was examined using immuno-histochemical methods in a group of 142 T 1 (F2 cm) ductal breast carcinomas. Immunostaining results were correlated with loss of apoptosis and clinicopathological parameters such as histological grade (HG) and lymph node involvement. Expression of anti-apoptotic proteins Bcl-2 and Bcl-x was found in 57.0% and 62.75% of tumors, respectively. Bcl-2 expression, but not Bcl-x expression, was related to loss of apoptosis. Expression of the apoptotic proteins Bax and Bak was present in 58% of Bcl-2-negative tumors and associated significantly with an increase in apoptosis. Expression of these DRPs was associated significantly with the HG of the tumors: Bcl-2 and Bak expression was predominant in HG I/II tumors, whereas expression of Bcl-x L and Bax was commonly observed in HG III tumors, as occurs for p53 over-expression. Our results suggest that the loss or gain of apoptosis is regulated tightly in T 1 breast carcinomas through the expression of different effectors along with tumor cell differentiation.
📜 SIMILAR VOLUMES
Apoptosis is an important physiological process controlled by multiple genes, including c-myc, p53 and bcl-2, and its inhibition may lead to the development of human cancers. In this study, we analyzed expression of the c-myc gene using Northern blot and of the p53 and bcl-2 proteins by immunohistoc
Previous reports have suggested that heterozygotes for ataxia-telangiectasia (A-T) have an increased risk of cancer, in particular breast cancer. The ATM gene, responsible for A-T, was recently cloned. Loss of heterozygosity (LOH) in the chromosome band 11q23, where the ATM gene is located, has been
We have developed an in vitro model to study mechanisms by which ovarian tumor cells that over-express the HER-2/ neu proto-oncogene escape recognition by T CD8 1 . Nine tumorspecific, HLA A2-restricted T CD8 1 clones were isolated from 2 ovarian tumor-specific T CD8 1 lines derived from tumorinfilt